RXD:NYE-ProShares UltraShort Health Care (USD)

ETF | Trading--Inverse Equity |

Last Closing

USD 9.5

Change

+0.13 (+1.39)%

Market Cap

N/A

Volume

0.01M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-20 )

Largest Industry Peers for Trading--Inverse Equity

Symbol Name Price(Change) Market Cap
SH ProShares Short S&P500

+0.04 (+0.36%)

USD 1.12B
SOXS Direxion Daily Semiconductor B..

+0.96 (+4.42%)

USD 0.75B
PSQ ProShares Short QQQ

+0.12 (+0.30%)

USD 0.62B
SPXU ProShares UltraPro Short S&P50..

+0.16 (+0.64%)

USD 0.52B
SDOW ProShares UltraPro Short Dow30

-0.02 (-0.15%)

USD 0.29B
SPDN Direxion Daily S&P 500® Bear ..

+0.02 (+0.18%)

USD 0.18B
RWM ProShares Short Russell2000

+0.21 (+1.11%)

USD 0.16B
DOG ProShares Short Dow30

-0.01 (-0.04%)

USD 0.16B
YANG Direxion Daily FTSE China Bear..

-0.02 (-0.26%)

USD 0.11B
FNGD MicroSectors FANG+ Index -3X I..

+0.25 (+1.18%)

USD 0.11B

ETFs Containing RXD

RLD:CA 0.00 % 0.61 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Inverse Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -20.37% 51% F 9% A-
Dividend Return 2.66% 81% B- 54% F
Total Return -17.71% 53% F 10% F
Trailing 12 Months  
Capital Gain -26.93% 62% D 7% C-
Dividend Return 3.38% 70% C- 49% F
Total Return -23.55% 62% D 8% B-
Trailing 5 Years  
Capital Gain -77.87% 59% D- 4% F
Dividend Return 2.46% 58% F 7% C-
Total Return -75.41% 57% F 4% F
Average Annual (5 Year Horizon)  
Capital Gain 1.77% 41% F 45% F
Dividend Return 2.79% 41% F 39% F
Total Return 1.02% 55% F 22% F
Risk Return Profile  
Volatility (Standard Deviation) 249.68% 61% D- 3% F
Risk Adjusted Return 1.12% 39% F 25% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.